Health
Health Stories
Development of indigenous multi-stage Malaria vaccine ‘AdFalciVax’ is underway – World News Network
The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax.
Development of indigenous multi-stage Malaria vaccine ‘AdFalciVax’ is underway – World News Network
The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax.
Development of indigenous multi-stage Malaria vaccine ‘AdFalciVax’ is underway – World News Network
The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax.
Development of indigenous multi-stage Malaria vaccine ‘AdFalciVax’ is underway – World News Network
The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax.
Development of indigenous multi-stage Malaria vaccine ‘AdFalciVax’ is underway – World News Network
The Indian Council of Medical Research (ICMR), through its Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR), in partnership with the Department of Biotechnology-National Institute of Immunology (DBT-NII), is currently developing a novel recombinant chimeric malaria vaccine candidate, named AdFalciVax.
Gene editing offers transformative solution to saving endangered species: Study – World News Network
Gene editing technologies, such as those used in agriculture and de-extinction efforts, can be repurposed to provide what an international team of scientists describes as a breakthrough approach for restoring genetic variety and rescuing endangered species.